<DOC>
	<DOCNO>NCT01600521</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety combine therapy rheumatoid arthritis ( RA ) . The combined therapy contain paeoniflorin ( Brand name : Pafulin ) , anti-inflammation property , Cervus Cucumis polypeptide injection ( Brand name : Songmeile ) , bone healing , pain relieving , anti-inflammation property . The hypothesis remedy , long use world 's large RA community , effective safe test modern clinical standard criterion .</brief_summary>
	<brief_title>A Clinical Study Natural Remedy Rheumatoid Arthritis v . Commonly Used Conventional Medications</brief_title>
	<detailed_description>This double-blinded randomized study treatment rheumatoid arthritis . In particular , patient randomly assign one follow treatment group : Paeoniflorin ( PAE ) + Cervus Cucumis polypeptide injection ( CCPI ) , Methotrexate ( MTX ) + Leflunomide ( LEF ) , MTX + LEF + CCPI . The therapeutic effectiveness evaluate 7 core set measure American College Rheumatology ( ACR ) . Adverse effect , severity , evaluator ' professional judgment relationship adverse effect drug document .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Leflunomide</mesh_term>
	<mesh_term>Peoniflorin</mesh_term>
	<criteria>age 18 year older active RA , define least 8 swollen joint least 10 tender joint ( exclude distal interphalangeal joint ) erythrocyte sedimentation rate ( ESR ) least 28 mm per hour 1987 revise American College Rheumatology ( ACR ) criteria diagnosis RA least 6 month use NSAIDs within two week agreement participate study . poor compliance severe medical condition abnormality liver , kidney function , haematological parameter , pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>